skip to Main Content
 

RSV Prevention, Part IV: Immunocompromised Populations

  • This page as PDF

Summary

Tune into the fourth episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the evolving landscape of RSV preventive products and considerations for both pediatric and adult populations with chronic medical conditions.

Panelists

Moderator
Sarah Moselle , Consultant II, Policy

Sarah Moselle supports clients with strategy development and implementation across a range of health policy and market access issues in US and international contexts.

Speaker
Haley Payne , Senior Associate, Policy

Haley Payne supports clients with evidence-based research and analysis that spans a variety of healthcare sectors and stakeholders.

Speaker
Elif Alyanak , Consultant II, Policy

Elif Alyanak supports clients with evidence-based research and analysis that spans a variety of healthcare sectors and stakeholders.

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Vaccines / Preventive Services
Please enter your email address to be notified when new Vaccines / Preventive Services insights are published.

Back To Top